$NVLX looking to incorporate their biotech with th
Post# of 63660
![](/assets/46931549/no_avatar_available_thumb.jpg)
"While Nuvilex, Inc. (OTCQB: NVLX) continues to lay the foundation for its medical marijuana subsidiary, Medical Marijuana Sciences, Inc. (MMS), a growing list of studies continue to prove that Cannabis is having a dramatic effect on different types of cancer. Executives at MMS are preparing to enter the medical marijuana industry with a very different approach. Some of the company's work will be based on the live-cell encapsulation technology Nuvilex owns the rights to use with regard to any and all types of cancer.
As Nuvilex and MMS COO Dr. Gerald Crabtree has said, it is the company's intent to be a leader in the industry, and to use its expertise in the biotechnology space to drive research that lends to the marijuana debate. He said, "MMS plans to develop treatments, which employ constituents of Cannabis together with the Cell-in-a-Box™ cellulose-based live-cell encapsulation technology, for some of the deadliest forms of cancer.""
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)